
SOSV's IndieBio is a startup accelerator that invests in early-stage deep tech biotech companies focused on synthetic biology and life sciences. Its strategy involves providing pre-seed and seed funding, wet lab infrastructure, and mentorship to mission-driven founders addressing significant challenges in human and planetary health.
67% of their portfolio is in Food & Agriculture. Their most common stage is series-a (50% of deals). Average disclosed round size is $17.2M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$1.5B
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $6.4M | Feb 2023 | |
| Seed | $2.5M | Nov 2022 | |
| Series B | $25M | May 2022 | |
| Series A | $36M | May 2022 | |
| NNew Age Meats | Series A | $25M | Sep 2021 |
| Series A | $8.3M | Jun 2021 |
Top Co-Investors
Siddhi Capital2 shared
CJ CheilJedang1 shared
HackCapital1 shared
Ospraie Ag Science1 shared
Future Fund1 shared
Grid Exponential1 shared
Impact America Fund1 shared
Better1 shared
Overlap Holdings1 shared
Khosla Ventures1 shared
Piva1 shared
B371 shared
Global Brain Corporation1 shared
Alumni Ventures Group1 shared
Horizon Ventures1 shared
Social Impact Capital1 shared
UBS1 shared
Last updated: 16 April 2026